Slide background
Slide background




Safe design and operation of on site generation of oxygen 93% for medical use

ID 1668 | | Visite: 4091 | Documenti Chemicals EntiPermalink: https://www.certifico.com/id/1668

Temi: Chemicals , EIGA



Safe design and operation of on site generation of oxygen 93% for medical use

Oxygen for medicinal use is a prime requirement for all healthcare facilities for both the treatment of patients with respiratory disease and for providing additional oxygen to patients being treated within the facility.

For those hospitals and clinics, where the demand is higher, oxygen is normally distributed throughout the facility using a medical gas pipeline system.

The design requirements for the supply source used to supply medical oxygen to the pipeline system are detailed in the standard, EN ISO 7396-1 Medical gas pipeline systems; Pipeline systems for compressed medical gases and vacuum.

Two different products are included in the standard:

- Medicinal oxygen supplied from liquid oxygen vessels and/or gaseous oxygen cylinders; and
- Oxygen 93 manufactured on-site within the healthcare facility, using an oxygen concentrator unit.

Medicinal oxygen supplied either in cylinders or as a cryogenic liquid, is required to be manufactured by an approved supplier with a manufacturers licence (to demonstrate compliance with guidelines detailed in the European Commission’s Guide to Good Manufacturing Practice (GMP))

Within the European Union, the supplier of medical oxygen is required to hold a marketing authorisation in accordance with Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, detailing the clinical indications and contraindications and specific warnings for the safe use of the product.

The specification of this medical oxygen is detailed in the European Pharmacopoeia monograph for medical oxygen, which specifies a minimum purity of 99.5% oxygen.

The quality, safety and efficacy of the medical oxygen are ensured by the medical gas supplier through a quality management system under the responsibility of a qualified person.

Oxygen 93 can be manufactured on-site within the healthcare facility, under the responsibility of the healthcare facility pharmacist, using an oxygen 93 supply system and meeting the appropriate and specific quality and safety criteria for medicinal products prepared in Pharmacies (see Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme Guide PE010-4 Guideline to good practices for the preparation of medicinal products in healthcare establishment).

Oxygen 93 is not being ‘put on the market’, so it currently falls outside the regulation for the manufacture and supply of medicinal product Directive 2001/83/EC.

Oxygen 93 concentrator units are covered by the requirements for CE marking in accordance with the Medical Device Directive, (Council Directive 93/42/EEC of 14 June 1993 concerning medical devices).

The specification of the oxygen manufactured using an oxygen 93 supply system is detailed in the European Pharmacopoeia monograph for oxygen 93, which specifies the oxygen content to be between 90% and 96% and gives appropriate limits and analysis methods of other possible contaminants during the production.

As the oxygen 93 is produced by adsorbing the nitrogen from ambient air, the major contaminant in oxygen 93 is argon, which can be present up to 5%.

When the oxygen 93% monograph was introduced it was stated that the benefits of PSA oxygen (oxygen 93 per cent) are to allow production and supply of oxygen at sites where access for cylinder and liquid oxygen supply is difficult or impossible. PSA concentrators are in use in a number of fields particularly by the military (field hospitals).

The quality of the gas is very much dependent upon the performance of the equipment that produces it.

At the time of preparation of this publication, oxygen 93 is not licensed under a marketing authorisation, thus it is not evaluated by regulatory authorities and thus it cannot be considered as “equivalent medicine” for the oxygen.

EIGA 2015

Pin It


Tags: Chemicals EIGA

Articoli correlati

Ultimi archiviati Chemicals

Set 25, 2020 19

DPCM 25 febbraio 2005

Decreto del Presidente del Consiglio dei Ministri del 25 febbraio 2005 Linee guida per la predisposizione del piano d'emergenza esterna di cui all´art. 20, comma 4, del decreto legislativo 17 agosto 1999 n. 334 (G.U. n. 61 del 16 marzo 2005 SO n. 40) Collegati[box-note]Seveso: timeline… Leggi tutto
Regolamento UE 2020 1245
Set 03, 2020 751

Regolamento (UE) 2020/1245

Regolamento (UE) 2020/1245 Regolamento (UE) 2020/1245 della Commissione del 2 settembre 2020 che modifica e rettifica il regolamento (UE) n. 10/2011 riguardante i materiali e gli oggetti di materia plastica destinati a venire a contatto con i prodotti alimentari GU L 288/1 del 03.09.2020… Leggi tutto
Convention on Nuclear Safety
Set 03, 2020 97

Convention on Nuclear Safety

Convention on Nuclear Safety The Convention on Nuclear Safety (CNS) aims to commit Contracting Parties operating land-based civil nuclear power plants to maintain a high level of safety by establishing fundamental safety principles to which States would subscribe. The Convention is based on the… Leggi tutto
Report 2019 PIC
Ago 31, 2020 105

Relazione Annuale 2019 esportazioni importazioni Regolamento PIC

Relazione Annuale 2019 esportazioni importazioni Regolamento PIC ECHA - Reports on PIC chemicals exported and imported under Regulation 649/2012 | 2019 Le notifiche delle società dell'UE relative all'esportazione di determinate sostanze chimiche pericolose al di fuori dell'Unione hanno continuato a… Leggi tutto
Linee guida gestione del rischio filiera acque modello Water Safety Plan
Ago 25, 2020 171

Linee guida gestione del rischio filiera acque modello Water Safety Plan

Linee guida gestione del rischio filiera acque modello Water Safety Plan Linee guida per la valutazione e gestione del rischio nella filiera delle acque destinate al consumo umano secondo il modello dei Water Safety Plan Rapporti ISTISAN 14/21 L’Organizzazione Mondiale della Sanità ha introdotto… Leggi tutto
Linee guida informazione apparecchiature trattamento acqua consumo umano
Ago 22, 2020 103

Linee guida informazione apparecchiature trattamento acqua consumo umano

Linee guida informazione apparecchiature trattamento acqua consumo umano Linee guida per l’informazione sulle apparecchiature per il trattamento dell’acqua destinata al consumo umano Rapporto ISTISAN 15 / 8 Le linee guida sono state elaborate al fine di contribuire a garantire un’adeguata… Leggi tutto
Linee guida dispositivi di trattamento acque destinate al consumo umano
Ago 22, 2020 186

Linee guida dispositivi di trattamento acque destinate al consumo umano

Linee guida dispositivi di trattamento acque destinate al consumo umano Linee guida sui dispositivi di trattamento delle acque destinate al consumo umano ai sensi del D.M. 7 febbraio 2012, n. 25 20 marzo 2013 - In allegato Il Ministero della salute, in collaborazione con l’Istituto superiore di… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Feb 28, 2020 35080

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto
Regolamento  CE  852 2004
Mar 06, 2019 29220

Regolamento (CE) N. 852/2004

Regolamento (CE) N. 852/2004 Regolamento (CE) N. 852/2004 del Parlamento europeo e del Consiglio del 29 aprile 2004 sull'igiene dei prodotti alimentari GU L 139/1 del 30.4.2004 Testo consolidato 2009Modificato da: Regolamento (CE) n. 1019/2008 della Commissione del 17 ottobre 2008 (GU L 277 7… Leggi tutto